HeartSciences Inc. Warrant closed at $0.04 on Sep 22, down 18.62%, 70.9% below its highest close since Jun 15. Volume of 5.4K shares was 0.57× its 20-day average (below normal).
Split-adjusted performance: +8.4% over one month.
In the quarter ended Jul 31, 2026, revenue was $2.10K, up 10.5% from a year earlier, with a net margin of -151064.0%.
Short interest was 1.3K shares at the Sep 15 settlement, down 35.1% from the prior report (1.0 days to cover).
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
What is HSCSW's market cap?
$76.47K, based on the Sep 22 close of $0.04.
What sector is HSCSW in?
Financials, in the Banking & Credit industry.
About HeartSciences Inc. Warrant
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
